ATE132502T1 - Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung - Google Patents

Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung

Info

Publication number
ATE132502T1
ATE132502T1 AT89911467T AT89911467T ATE132502T1 AT E132502 T1 ATE132502 T1 AT E132502T1 AT 89911467 T AT89911467 T AT 89911467T AT 89911467 T AT89911467 T AT 89911467T AT E132502 T1 ATE132502 T1 AT E132502T1
Authority
AT
Austria
Prior art keywords
antibodies
beta
ifn
application
peptides representing
Prior art date
Application number
AT89911467T
Other languages
English (en)
Inventor
Paul D Hoeprich Jr
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Application granted granted Critical
Publication of ATE132502T1 publication Critical patent/ATE132502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89911467T 1988-10-14 1989-10-04 Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung ATE132502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25765188A 1988-10-14 1988-10-14

Publications (1)

Publication Number Publication Date
ATE132502T1 true ATE132502T1 (de) 1996-01-15

Family

ID=22977172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89911467T ATE132502T1 (de) 1988-10-14 1989-10-04 Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung

Country Status (7)

Country Link
US (1) US5869603A (de)
EP (1) EP0440686B1 (de)
JP (1) JP2717319B2 (de)
AT (1) ATE132502T1 (de)
CA (1) CA2000420C (de)
DE (1) DE68925365T2 (de)
WO (1) WO1990003982A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7272636B2 (en) * 2001-04-24 2007-09-18 Sun Microsystems, Inc. Peer group name server
JP2005029471A (ja) * 2001-06-26 2005-02-03 Toray Ind Inc ペプチドの立体構造モチーフおよび３次元構造座標ならびにそれらの使用
US20040086874A1 (en) * 2002-10-31 2004-05-06 Parker Russell A. Devices and methods for holding a biopolymeric array
HRP20230605T1 (hr) 2016-04-29 2023-09-29 Pfizer Inc. Protutijela protiv interferona beta i njihova upotreba

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311639A (en) * 1980-07-25 1982-01-19 E. I. Du Pont De Nemours And Company Immunogenic interferon peptides
GB8412564D0 (en) * 1984-05-17 1984-06-20 Searle & Co Structure and properties

Also Published As

Publication number Publication date
JP2717319B2 (ja) 1998-02-18
DE68925365D1 (de) 1996-02-15
DE68925365T2 (de) 1996-09-12
JPH07508494A (ja) 1995-09-21
CA2000420C (en) 2000-12-19
EP0440686B1 (de) 1996-01-03
CA2000420A1 (en) 1990-04-14
EP0440686A1 (de) 1991-08-14
US5869603A (en) 1999-02-09
WO1990003982A1 (en) 1990-04-19

Similar Documents

Publication Publication Date Title
NO951212D0 (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
EP0724651A4 (de) Synthetische humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch
DE69429095D1 (de) Humanisierte antikoerper
ATE207080T1 (de) Multivalente antigen-bindende proteine
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
DE59914538D1 (de) Tetravalente Antikörperkonstrukte
ATE481480T1 (de) Methoden und zusammensetzungen zur herstellung von polypeptiden
DE69636450D1 (de) PEPTIDE UND PEPTIDOMIMETIKA MIT STRUKTURELLER ÄHNLICHKEIT MIT p53 UND DIE DIE p53-FUNKTION AKTIVIEREN
NZ568769A (en) Human monoclonal antibodies against CD20
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ES2187954T3 (es) Anticuerpos anti-integrina avb3 antagonistas.
DE69737683D1 (de) Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
SG52589A1 (en) Antigenic epitopes presend on membrane-bound but not secreted iga
ATE425251T1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
ATE427488T1 (de) Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ATE120233T1 (de) Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
ATE132502T1 (de) Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
ATE120209T1 (de) Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit.
ATE208403T1 (de) Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
FI934963A7 (fi) CTAA 81AV78, monoklonaalisen 81AV78-humaanivasta-aineen tunnistama ant igeeni

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee